To establish a platform for high throughput screening and in vitro evaluating novel metabolic enzyme-targeted inhibitors towards anti-malarial drugs,a lactate dehydrogenase gene of Plasmodium falciparum (PfLDH) was amplified from the Hainan isolate FCC1/HN. The fusion expression vectors,pGEX-2TK and pET-29a(+),were utilized to introduce the PfLDH gene into strains of Escherichia coli,BL21 and BL21(DE3),for over-expression. Consequently,the enzymatic activity of PfLDH was successfully detected in the suspension of lytic bacteria. The PfLDH gene cloned in pGEX-2TK was mainly expressed as inclusion bodies,while the same gene cloned in pET-29a(+) was nearly expressed in a soluble form of PfLDH,demonstrating the latter vehicle might be more suitable for the large-scale preparation of recombinant PfLDH. Furthermore,according to the electrophoregram of SDS-PAGE and the sequencing data,a series of truncated PfLDH sequences generated randomly from gene amplification were screened and cloned,from which four pre-matured genes with a terminator mutation,PfLDH-Δ271,-Δ236,-Δ167 and -Δ53 coding for 45,80,149 and 263 amino acid residues, were individually recovered. Through the gene expression and enzymatic activity measurement,the effect of pre-matured terminator mutation on the activity of PfLDH was evaluated,which should pave the way for probing the relationship between structure and function of PfLDH.